Correct me if im wrong , but was there an In vitro study started late last year with QPS Neuro. regarding protein uptakes and degeneration levels aimed squarely at Alzheimers ? The pathway to validation regarding stroke is well documented but theres a few unknowns that could pop up at anytime regarding the other indicators (TBI, HIE Alz etc) Assuming we get some prelim safety data on stroke late Q2 , the next 6 months should be very interesting. Imo they have also in the meantime been getting the board in a position to do deals / avoid losing our value, you cant help but be optimistic looking forward
Anything under a cheeky dollar this is a steal, page-7
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.5¢ |
Change
-0.025(3.25%) |
Mkt cap ! $95.42M | |||
| Open | High | Low | Value | Volume |
| 78.0¢ | 78.0¢ | 73.5¢ | $85.13K | 113.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6375 | 74.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 7000 | 1 |
View Market Depth
| Last trade - 15.24pm 04/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |